article thumbnail

STEERLife and Callidus Research Laboratories partner to accelerate drug development

Express Pharma

STEERLife, and Callidus Research Laboratories have forged a strategic partnership to accelerate drug development for global markets. The post STEERLife and Callidus Research Laboratories partner to accelerate drug development appeared first on Express Pharma.

article thumbnail

OneSource Specialty Pharma enters into strategic licensing agreement with Bhami’s Research Laboratory

Express Pharma

OneSource Specialty Pharma, associate company of Strides and reportedly India’s first specialty pharma pure-play CDMO (Contract Development and Manufacturing Organisation) has entered into a strategic licensing agreement with Bhami’s Research Laboratory (BRL).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

PharmaTech

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

article thumbnail

STAT+: Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster

STAT

“At Merck, we continue to assemble a strong and diversified oncology pipeline spanning differentiated mechanisms and multiple modalities,” said Dean Li, the president of Merck Research Laboratories, in a statement.

article thumbnail

STAT+: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’

STAT

Ebert, chair of Dana-Farber’s medical oncology department and a prize-winning researcher, will take over from Glimcher on Oct. In his current role Ebert oversees more than half of Dana-Farber’s 556 faculty members and more than 80 research laboratories. 1, the Boston institute said in a statement on Tuesday.

article thumbnail

STAT+: SEC wants to know if key supplier of research monkeys bribed foreign officials

STAT

The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing. ( See page 42.)

article thumbnail

STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys

STAT

 The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing.